Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known case was identified in Wuhan, China, in December 2019, and the disease has since spread worldwide, leading to a pandemic.

Infographics to support smokers quit smoking in the times of COVID-19

Infographics to support smokers quit smoking and prevent the ex-smokers relapse back to smoking: now and in the foreseeable times of high levels of anxiety and stress in the community. Help prevent another significant health calamity after the covid pandemic. You can download and use the infographics: these are free for use for everyone, to help people stay away from cigarettes.

English Website

EMCDDA trendspotter briefing - Impact of COVID-19 on drug services and help-seeking in Europe

Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this outbreak for drug services in Europe, the European Monitoring Centre for Drugs and Drug Addiction instigated a mixed-method trendspotter study to provide a snapshot of the current situation. This exercise provides a rapid assessment of the state of play in respect to the impact of COVID-19 on service provision and help-seeking behaviour among people who use drugs.

English Website

NLO briefing paperCOVID-19 in marginalised groups:challenges, actions and voices

The coronavirus disease (COVID-19) pandemic has created an unprecedented crisis for governments, health systems and societies at large, and has severely impacted the health, lives and livelihood of millions of people worldwide.

Marginalised groups are among people the hardest hit by the COVID-19 pandemic, and yet are among the least protected from it by governmental actions to date. Indeed, the COVID-19 crisis has brought into sharp focus the stark inequities that exist in access to health and social support services for marginalised people who live precariously in Europe, often outside formal healthcare systems and social, labour and legal protection measures.

The Nobody Left Outside coalition has developed this briefing paper for the WHO European Office for Investment for Health

English PDF Document

Voices of Frontline Workers Harm Reduction Responses in the European Region During the COVID-19 Pandemic

This Correlation European Harm Reduction Network
(C-EHRN) report on the impact of COVID-19 on vital
harm reduction services seeks to bring these voices
of front-line workers at drug consumption rooms
(DCR’s), harm reduction outreach teams and
PWUD themselves to highlight their experiences
during the COVID-19 pandemic.

English PDF Document

Lessons from COVID-19to reshape a sustainable response to HIV, TBand HCV among inadequately served populationsin the countries of Eastern Europe and Central Asia

As a result of the COVID-19 pandemic, health systems around the world have to become more robust, flexible, and results-oriented.Changes have been made in the approach that some health systems have taken to the delivery of a range of services, including interventions for the management of HIV and opioid dependence as well as the treatment of tuberculosis (TB) and viral hepatitis C (HCV) among key population groups. Many of these changes have been welcomed by communities, with a window of opportunity to revisit and refresh issues of drug use regulations, policing, amnesty for people in prisons and other closed settings.

English PDF Document


In August 2020 AFEW International conducted a questionnaire among Civil Society Organisations in Eastern Europe and Central Asia to measure the impact of COVID-19 on CSOs in the region. The results of the survey are now published in the report “The impact of COVID-19 on civil society organisations in Eastern Europe and Central Asia”.

English PDF Document

In partnership with:
Correlation Network